Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Malignant Tumor”

6,026 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,026 results

Early research (Phase 1)Study completedNCT03525925
What this trial is testing

Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 16
Not applicableLooking for participantsNCT05022446
What this trial is testing

The Impact of COVID-19 on Pulmonary Procedures

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 250
Early research (Phase 1)Not Yet RecruitingNCT05474859
What this trial is testing

Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Xenthera, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT05423262
What this trial is testing

TRK-950 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorMelanoma
Toray Industries, Inc 49
Early research (Phase 1)Study completedNCT00874042
What this trial is testing

Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 74
Not applicableLooking for participantsNCT04243720
What this trial is testing

Immune Resistance Interrogation Study

Who this might be right for
CancerSolid TumorMetastatic Cancer+1 more
University Health Network, Toronto 100
Early research (Phase 1)Study completedNCT00516724
What this trial is testing

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Who this might be right for
Triple Negative Metastatic Breast CancerAdvanced Ovarian CancerCarboplatin+1 more
AstraZeneca 189
Early research (Phase 1)Study completedNCT02323880
What this trial is testing

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

Who this might be right for
Malignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more
Children's Oncology Group 59
Large-scale testing (Phase 3)Looking for participantsNCT03750227
What this trial is testing

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

Who this might be right for
Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain
Mayo Clinic 140
Not applicableStudy completedNCT00096590
What this trial is testing

Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery

Who this might be right for
ThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT03673020
What this trial is testing

Phase 1a Study to Evaluate Immunogenicity of ASV®

Who this might be right for
Solid Tumor, Adult
Agenus Inc. 3
Early research (Phase 1)Study completedNCT05735366
What this trial is testing

SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Chugai Pharmaceutical 22
Early research (Phase 1)Study completedNCT00698243
What this trial is testing

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Any Solid Tumor or Lymphoma
Astellas Pharma Inc 128
Early research (Phase 1)Study completedNCT00112476
What this trial is testing

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage IV Melanoma+2 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT01128842
What this trial is testing

Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor

Who this might be right for
Advanced Malignant Solid Tumors
Puma Biotechnology, Inc. 7
Early research (Phase 1)Ended earlyNCT05101213
What this trial is testing

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Who this might be right for
Adenovirus InfectionBK Virus InfectionCytomegaloviral Infection+4 more
M.D. Anderson Cancer Center 12
Early research (Phase 1)Study completedNCT05990920
What this trial is testing

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

Who this might be right for
Pathologically Confirmed Cancer Refractory to Conventional TherapyRefractory CancerMetastatic Cancer+5 more
NKGen Biotech, Inc. 6
Not applicableStudy completedNCT04337203
What this trial is testing

Shared Healthcare Actions and Reflections Electronic Systems in Survivorship

Who this might be right for
CancerSurvivorshipHematopoietic and Lymphoid Cell Neoplasm+1 more
Wake Forest University Health Sciences 40
Early research (Phase 1)Ended earlyNCT06028373
What this trial is testing

ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Who this might be right for
Advanced Solid TumorsB-cell Non-Hodgkin Lymphomas
Antengene Biologics Limited 38
Early research (Phase 1)UnknownNCT04864379
What this trial is testing

Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Sir Run Run Shaw Hospital 30
Next Page